Enanta Pharmaceuticals
ENTA
#8020
Rank
โ‚น16.69 B
Marketcap
โ‚น787.90
Share price
0.32%
Change (1 day)
-4.86%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2024 (TTM): -โ‚น8.88 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น71.96 Million. In 2023 the company made an earning of -โ‚น10.75 Billion a decrease over its 2022 earnings that were of -โ‚น10.3 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚น8.88 Billion-17.39%
2023 -โ‚น10.75 Billion4.39%
2022 -โ‚น10.3 Billion-4.4%
2021 -โ‚น10.78 Billion91.12%
2020 -โ‚น5.64 Billion-407.13%
2019 โ‚น1.83 B-78.63%
2018 โ‚น8.58 B117.97%
2017 โ‚น3.94 B-574.65%
2016 -โ‚น0.84 Billion-110.83%
2015 โ‚น7.66 B-4.5%
2014 โ‚น8.02 B-638.53%
2013 -โ‚น1.5 Billion-137.98%
2012 โ‚น3.92 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚น596.07 B-6,727.96%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.551 T-17,354.64%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น21.63 B-340.60%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.391 T-15,567.74%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น580.39 Billion 6,353.49%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.074 T-12,042.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland